Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Sell
1,081
-174
-14% -$2.59K ﹤0.01% 2772
2026
Q1
$19.3K Buy
1,255
+64
+5% +$1.07K ﹤0.01% 2498
2025
Q4
$21.5K Buy
1,191
+78
+7% +$1.34K ﹤0.01% 2249
2025
Q3
$17.9K Buy
1,113
+180
+19% +$2.63K ﹤0.01% 2302
2025
Q2
$10.2K Buy
933
+175
+23% +$1.96K ﹤0.01% 2472
2025
Q1
$9.46K Sell
758
-18
-2% -$297 ﹤0.01% 2457
2024
Q4
$15.4K Buy
776
+526
+210% +$5.83K ﹤0.01% 2255
2024
Q3
$2.04K Sell
250
-506
-67% -$3.44K ﹤0.01% 2889
2024
Q2
$5.15K Buy
+756
New +$5.17K ﹤0.01% 2539
2023
Q3
Sell
-95
Closed -$743 3442
2023
Q2
$743 Hold
95
﹤0.01% 3007
2023
Q1
$625 Buy
+95
New +$629 ﹤0.01% 3056
2022
Q2
Sell
-84
Closed -$1K 3211
2022
Q1
$1K Sell
84
-290
-78% -$2.47K ﹤0.01% 2784
2021
Q4
$4K Buy
374
+22
+6% +$256 ﹤0.01% 2490
2021
Q3
$4K Hold
352
﹤0.01% 2473
2021
Q2
$5K Hold
352
﹤0.01% 2302
2021
Q1
$6K Hold
352
﹤0.01% 2133
2020
Q4
$6K Hold
352
﹤0.01% 1974
2020
Q3
$13K Sell
352
-44
-11% -$1.38K ﹤0.01% 1624
2020
Q2
$9K Buy
+396
New +$8.48K ﹤0.01% 1758
2020
Q1
Sell
-270
Closed -$4K 2540
2019
Q4
$4K Hold
270
﹤0.01% 2032
2019
Q3
$4K Hold
270
﹤0.01% 1991
2019
Q2
$3K Buy
+270
New +$2.85K ﹤0.01% 1998
2018
Q4
Sell
-419
Closed -$7K 2208
2018
Q3
$7K Buy
419
+285
+213% +$3.62K ﹤0.01% 1588
2018
Q2
$1K Hold
134
﹤0.01% 1986
2018
Q1
$2K Buy
+134
New +$1.61K ﹤0.01% 1851

Other funds holding MESO

Parallel Advisors's MESO Position: Q2 2026 in Review

Parallel Advisors reduced its Mesoblast (MESO) stake by 14% in Q2 2026, selling an estimated $2.59K and leaving 1,081 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Parallel Advisors first reported a position in MESO in Q1 2018 and has held it in 25 quarters since. The position peaked at $21.5K in Q4 2025. 53 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Parallel Advisors held 1,081 shares of Mesoblast worth $14.6K as of Q2 2026.
  • Parallel Advisors sold 174 Mesoblast shares in Q2 2026, an estimated $2.59K.
  • Mesoblast made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2772 holding.
  • Parallel Advisors first reported a position in Mesoblast in Q1 2018 and has held it in 25 quarters since.
  • Parallel Advisors's Mesoblast position peaked at $21.5K in Q4 2025.
  • 53 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.